BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31878859)

  • 1. Preliminary Anti-Coxsackie Activity of Novel 1-[4-(5,6-dimethyl(H)- 1H(2H)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas.
    Piras S; Corona P; Ibba R; Riu F; Murineddu G; Sanna G; Madeddu S; Delogu I; Loddo R; Carta A
    Med Chem; 2020; 16(5):677-688. PubMed ID: 31878859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anti-picornaviridae in vitro activity of a new class of helicase inhibitors the N,N'-bis[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl] alkyldicarboxamides.
    Carta A; Loriga M; Piras S; Paglietti G; Ferrone M; Fermeglia M; Pricl S; La Colla P; Collu G; Sanna T; Loddo R
    Med Chem; 2007 Nov; 3(6):520-32. PubMed ID: 18045201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides.
    Carta A; Loriga G; Piras S; Paglietti G; Ferrone M; Fermeglia M; Pricl S; La Colla P; Secci B; Collu G; Loddo R
    Med Chem; 2006 Nov; 2(6):577-89. PubMed ID: 17105439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antiviral activity and structure-activity relationship of 1-(1-aryl-4,5-dihydro-1H-imidazoline)-3-chlorosulfonylureas and products of their cyclization.
    Rządkowska M; Szacoń E; Kaczor AA; Rajtar B; Świątek Ł; Polz-Dacewicz M; Matosiuk D
    J Enzyme Inhib Med Chem; 2016 Oct; 31(5):787-95. PubMed ID: 26212601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5.
    Loddo R; Novelli F; Sparatore A; Tasso B; Tonelli M; Boido V; Sparatore F; Collu G; Delogu I; Giliberti G; La Colla P
    Bioorg Med Chem; 2015 Nov; 23(21):7024-34. PubMed ID: 26443549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents.
    Tonelli M; Novelli F; Tasso B; Vazzana I; Sparatore A; Boido V; Sparatore F; La Colla P; Sanna G; Giliberti G; Busonera B; Farci P; Ibba C; Loddo R
    Bioorg Med Chem; 2014 Sep; 22(17):4893-909. PubMed ID: 25082514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Evolution of Pleconaril: Modified
    Volobueva A; Egorova A; Galochkina A; Ekins S; Zarubaev V; Makarov V
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32188089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinoxaline derivatives as new inhibitors of coxsackievirus B5.
    Carta A; Sanna G; Briguglio I; Madeddu S; Vitale G; Piras S; Corona P; Peana AT; Laurini E; Fermeglia M; Pricl S; Serra A; Carta E; Loddo R; Giliberti G
    Eur J Med Chem; 2018 Feb; 145():559-569. PubMed ID: 29339251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient synthesis and anti-enteroviral activity of 9-arylpurines.
    Aguado L; Canela MD; Thibaut HJ; Priego EM; Camarasa MJ; Leyssen P; Neyts J; Pérez-Pérez MJ
    Eur J Med Chem; 2012 Mar; 49():279-88. PubMed ID: 22305341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
    Cheng J; Xie J; Luo X
    Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
    Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiviral activity of a new series of 4-isothiazolecarbonitriles.
    Cutrí CC; Garozzo A; Siracusa MA; Sarvá MC; Tempera G; Geremia E; Pinizzotto MR; Guerrera F
    Bioorg Med Chem; 1998 Dec; 6(12):2271-80. PubMed ID: 9925289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus.
    Pinkert S; Dieringer B; Diedrich S; Zeichhardt H; Kurreck J; Fechner H
    Antiviral Res; 2016 Dec; 136():1-8. PubMed ID: 27773751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation.
    Fioravanti R; Desideri N; Carta A; Atzori EM; Delogu I; Collu G; Loddo R
    Eur J Med Chem; 2017 Dec; 141():15-25. PubMed ID: 29028528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds.
    Bernard A; Lacroix C; Cabiddu MG; Neyts J; Leyssen P; Pompei R
    Antivir Chem Chemother; 2015 Apr; 24(2):56-61. PubMed ID: 26071135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents.
    Küçükgüzel I; Tatar E; Küçükgüzel SG; Rollas S; De Clercq E
    Eur J Med Chem; 2008 Feb; 43(2):381-92. PubMed ID: 17583388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-enteroviral activity of new MDL-860 analogues: Synthesis, in vitro/in vivo studies and QSAR analysis.
    Nikolova I; Slavchev I; Ravutsov M; Dangalov M; Nikolova Y; Zagranyarska I; Stoyanova A; Nikolova N; Mukova L; Grozdanov P; Nikolova R; Shivachev B; Kuz'min VE; Ognichenko LN; Galabov AS; Dobrikov GM
    Bioorg Chem; 2019 Apr; 85():487-497. PubMed ID: 30782563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2.
    Kolocouris N; Kolocouris A; Foscolos GB; Fytas G; Neyts J; Padalko E; Balzarini J; Snoeck R; Andrei G; De Clercq E
    J Med Chem; 1996 Aug; 39(17):3307-18. PubMed ID: 8765514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.
    Xue F; Luo X; Ye C; Ye W; Wang Y
    Bioorg Med Chem; 2011 Apr; 19(8):2641-9. PubMed ID: 21441033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-CVB 3 evaluation of substituted 5-nitro-2-phenoxybenzonitriles.
    Pürstinger G; De Palma AM; Zimmerhofer G; Huber S; Ladurner S; Neyts J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5123-5. PubMed ID: 18710805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.